We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-British grandma is 1st in world to get Pfizer vaccine outside trial

Tue, 08th Dec 2020 07:09

* 90-year-old grandmother gets Pfizer vaccine

* Britain rolls out COVID vaccine, first in the West

* 'I feel so privileged' says first vaccine recipient
(Adds details, UK context)

By Kate Holton

LONDON, Dec 8 (Reuters) - Margaret Keenan, a 90-year-old
grandmother, on Tuesday became the first person in the world to
receive the Pfizer COVID-19 vaccine shot outside of a
trial as Britain began vaccinating its population.

An early riser, Keenan received the vaccine at her local
hospital in Coventry, central England, on Tuesday morning at
0631 GMT, a week before she turns 91.

Britain began rolling out the COVID-19 vaccine developed by
Pfizer and BioNTech on Tuesday, the first Western country to
start vaccinating its general population in what was hailed as a
decisive watershed in defeating the coronavirus.

"I feel so privileged to be the first person vaccinated
against Covid-19," said Keenan, as she received the jab from a
nurse originally from the Philippines in front of a photographer
and TV crew.

"It's the best early birthday present I could wish for
because it means I can finally look forward to spending time
with my family and friends in the New Year after being on my own
for most of the year."

Keenan, known as Maggie to her friends, is a former
jewellery shop assistant who only retired four years ago. She
has a daughter, a son and four grandchildren.

Video footage shows her wearing a medical mask along with a
blue t-shirt and cardigan while she receives the shot from nurse
May Parsons.

Parsons, who has worked in Britain's National Health Service
for 24 years, said the last few months had been tough on
everyone but it felt like there was now light at the end of the
tunnel.

Britain is the worst-hit European country from COVID-19,
with over 61,000 deaths, but Prime Minister Boris Johnson hopes
to turn the tide against the disease by rolling out the
Pfizer/BioNTech vaccine before the United States or European
Union.

The mass inoculation will fuel hope that the world may be
turning a corner in the fight against a pandemic that has
crushed economies and killed more than 1.5 million, although
ultra-cold storage and tricky logistics will limit its use for
now.

British Health Secretary Matt Hancock and Stephen Powis,
medical director for NHS England, said they both found it very
emotional watching the vaccine programme roll out.

The BBC also carried an interview with another elderly lady
who will receive the vaccine today, very upset after she lost
her husband from COVID-19 earlier in the year.

Britain has ordered 40 million doses of the Pfizer/BioNTech
shot. As each person requires two doses, that is enough to
vaccinate 20 million people in the country of 67 million.

About 800,000 doses are expected to be available within the
first week, with care home residents and carers, the over 80s
and some health service workers the top priority to get them.
(Reporting by Kate Holton, editing by Estelle Shirbon/Guy
Faulconbridge)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.